A Study of Olezarsen for the Treatment of Familial Chylomicronemia Syndrome (FCS) in Pediatric Participants

NCT07727538 · clinicaltrials.gov ↗

PHASE3

Phase

RECRUITING

Status

12

Enrollment

INDUSTRY

Sponsor class

Conditions

Familial Chylomicronemia Syndrome

Interventions

DRUG: Olezarsen

Sponsor

Ionis Pharmaceuticals, Inc.